These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27015910)

  • 1. Effective drug therapy for cocaine dependence: a milestone.
    Dürsteler KM; Vogel M
    Lancet; 2016 May; 387(10034):2171-3. PubMed ID: 27015910
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.
    Nuijten M; Blanken P; van de Wetering B; Nuijen B; van den Brink W; Hendriks VM
    Lancet; 2016 May; 387(10034):2226-34. PubMed ID: 27015909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients.
    Herbrink M; Nuijten M; Nuijen B; Huitema ADR; Beijnen JH; Hendriks VM; Blanken P; Janmohamed A; van den Brink W
    J Clin Psychopharmacol; 2018 Jun; 38(3):212-217. PubMed ID: 29620701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys.
    Czoty PW; Martelle JL; Nader MA
    Psychopharmacology (Berl); 2010 May; 209(4):375-82. PubMed ID: 20217052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.
    Castells X; Casas M; Vidal X; Bosch R; Roncero C; Ramos-Quiroga JA; Capellà D
    Addiction; 2007 Dec; 102(12):1871-87. PubMed ID: 18031423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.
    Bolin BL; Stoops WW; Sites JP; Rush CR
    J Addict Med; 2016; 10(3):156-65. PubMed ID: 26933876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2003 May; 167(3):324-32. PubMed ID: 12652348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality rate among crack/cocaine-dependent patients: a 12-year prospective cohort study conducted in Brazil.
    Dias AC; Araújo MR; Dunn J; Sesso RC; de Castro V; Laranjeira R
    J Subst Abuse Treat; 2011 Oct; 41(3):273-8. PubMed ID: 21550198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can replacement therapy work in the treatment of cocaine dependence? And what are we replacing anyway?
    Vocci FJ
    Addiction; 2007 Dec; 102(12):1888-9. PubMed ID: 18031424
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies.
    Fischer B; Blanken P; Da Silveira D; Gallassi A; Goldner EM; Rehm J; Tyndall M; Wood E
    Int J Drug Policy; 2015 Apr; 26(4):352-63. PubMed ID: 25662894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers.
    Vansickel AR; Fillmorex MT; Hays LR; Rush CR
    Am J Drug Alcohol Abuse; 2008; 34(3):293-305. PubMed ID: 18428072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crack Cocaine Use in Adolescents: Clinical Characteristics and Predictors of Early Initiation.
    Pianca TG; Rohde LA; Rosa RL; Begnis AP; Ferronatto PB; Jensen MC; Pechansky F; Ceresér KM; Fairchild VP; Szobot CM
    J Clin Psychiatry; 2016 Oct; 77(10):e1205-e1210. PubMed ID: 27574840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the dose in the therapeutic range?
    Kramer J
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S47. PubMed ID: 9988930
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it truly random?
    Markey P
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S48. PubMed ID: 9988931
    [No Abstract]   [Full Text] [Related]  

  • 16. Crack cocaine--a two-year follow-up of treated patients.
    Laranjeira R; Rassi R; Dunn J; Fernandes M; Mitsuhiro S
    J Addict Dis; 2001; 20(1):43-8. PubMed ID: 11286430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of stimulant misusers: one year follow-up results from the national treatment outcome research study (NTORS).
    Gossop M; Marsden J; Stewart D
    Addict Behav; 2000; 25(4):509-22. PubMed ID: 10972443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.
    Fischer B; Kuganesan S; Gallassi A; Malcher-Lopes R; van den Brink W; Wood E
    Int J Drug Policy; 2015 Dec; 26(12):1177-82. PubMed ID: 26500166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients.
    Vogel M; Bucher P; Strasser J; Liechti ME; Krähenbühl S; Dürsteler KM
    J Psychoactive Drugs; 2016; 48(2):93-100. PubMed ID: 26940988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse outcomes in a controlled trial of pergolide for cocaine dependence.
    Malcolm R; Herron J; Sutherland SE; Brady KT
    J Addict Dis; 2001; 20(1):81-92. PubMed ID: 11286433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.